CIK 0001551306 · Large accelerated filer
Progyny, Inc.
Sign in to watch- Ticker
- PGNY
- Exchange
- Nasdaq
- Industry
- Services-Misc Health & Allied Services, NEC
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 272220139
- Phone
- 212-888-3124
- Business address
- 1359 BROADWAY, 2ND FLOOR, NEW YORK, NY, 10018
- Former names
- Auxogyn, Inc., Auxogyn Inc
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Planned sale CHIEF EXECUTIVE OFFICER sold 173,247 shares at an average $35.68 ($6,182,254)
- 4 Planned sale Executive Chairman sold 164,608 shares at an average $35.72 ($5,879,116)
- 4 Planned sale CHIEF FINANCIAL OFFICER sold 2,139 shares at $30.00 ($64,170)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 10-Q Report Quarterly Report
- 4 Grant or award EVP, GC acquired 8,160 shares (grant or award)
- 8-K Event Results of operations · Regulation FD disclosure
- 144 Insider Sale of Securities
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Planned sale Chief Operating Officer sold 1,879 shares at $28.00 ($52,612)
- 144 Insider Sale of Securities
- 4 Planned sale EVP, GC sold 3,903 shares at $26.10 ($101,868)
- 144 Insider Sale of Securities
- 4 Shares withheld for taxes Chief Product Officer gave up 819 shares (to pay taxes)
- 4/A Open-market sale Director sold 11,500 shares at $27.12 ($311,858)
- 4 Open-market sale Director sold 11,500 shares at $27.94 ($321,358)
Page 1 of 48 · 942 filings